Thomas E. Denion

Array ( [id] => 7295883 [patent_doc_number] => 20040214184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Small peptides capable of modulating the function of cd66 (ceacam) family members' [patent_app_type] => new [patent_app_number] => 10/469273 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14944 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214184.pdf [firstpage_image] =>[orig_patent_app_number] => 10469273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7601658 [patent_doc_number] => 07385044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Isolated peptides which bind to MHC Class II molecules, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/851884 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 12509 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/385/07385044.pdf [firstpage_image] =>[orig_patent_app_number] => 10851884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 719507 [patent_doc_number] => 07049082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Methods, products and treatments for diabetes' [patent_app_type] => utility [patent_app_number] => 10/833581 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 10362 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049082.pdf [firstpage_image] =>[orig_patent_app_number] => 10833581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7183620 [patent_doc_number] => 20040203127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/827272 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19920 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203127.pdf [firstpage_image] =>[orig_patent_app_number] => 10827272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7212174 [patent_doc_number] => 20050054090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'MHC class II antigen-presenting systems and methods for activating CD4cells' [patent_app_type] => utility [patent_app_number] => 10/822173 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25421 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054090.pdf [firstpage_image] =>[orig_patent_app_number] => 10822173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062557 [patent_doc_number] => 20070224196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon' [patent_app_type] => utility [patent_app_number] => 10/551525 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23245 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224196.pdf [firstpage_image] =>[orig_patent_app_number] => 10551525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239704 [patent_doc_number] => 07592421 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-22 [patent_title] => 'HLA class II peptide mimics' [patent_app_type] => utility [patent_app_number] => 10/804392 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 5189 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592421.pdf [firstpage_image] =>[orig_patent_app_number] => 10804392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111131 [patent_doc_number] => 20050208586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Using complement component C1q derived molecules as tracers for fluorescence polarization assays' [patent_app_type] => utility [patent_app_number] => 10/803246 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5157 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208586.pdf [firstpage_image] =>[orig_patent_app_number] => 10803246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840453 [patent_doc_number] => 07390782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Methods and products related to metabolic interactions in disease' [patent_app_type] => utility [patent_app_number] => 10/802440 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 38 [patent_no_of_words] => 41824 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390782.pdf [firstpage_image] =>[orig_patent_app_number] => 10802440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341416 [patent_doc_number] => 20040191242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Method for producing a vaccine' [patent_app_type] => new [patent_app_number] => 10/472876 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9710 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191242.pdf [firstpage_image] =>[orig_patent_app_number] => 10472876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7383672 [patent_doc_number] => 20040180046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Bispecific molecules and uses thereof' [patent_app_type] => new [patent_app_number] => 10/258650 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19584 [patent_no_of_claims] => 119 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180046.pdf [firstpage_image] =>[orig_patent_app_number] => 10258650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405343 [patent_doc_number] => 20040175745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/785106 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 19054 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175745.pdf [firstpage_image] =>[orig_patent_app_number] => 10785106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7249638 [patent_doc_number] => 20040258697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Methods of using multivalent MHC class II-peptide chimeras' [patent_app_type] => new [patent_app_number] => 10/785705 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7776 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258697.pdf [firstpage_image] =>[orig_patent_app_number] => 10785705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7324033 [patent_doc_number] => 20040137617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Purification of antigen-specific T cells' [patent_app_type] => new [patent_app_number] => 10/785472 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 9450 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137617.pdf [firstpage_image] =>[orig_patent_app_number] => 10785472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655204 [patent_doc_number] => 20060140939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury' [patent_app_type] => utility [patent_app_number] => 10/545700 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10640 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140939.pdf [firstpage_image] =>[orig_patent_app_number] => 10545700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334774 [patent_doc_number] => 20040132088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Expression vectors encoding epitopes of target-associated antigens and methods for their design' [patent_app_type] => new [patent_app_number] => 10/777053 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 39864 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132088.pdf [firstpage_image] =>[orig_patent_app_number] => 10777053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303214 [patent_doc_number] => 20040115191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Method for treating psoriasis' [patent_app_type] => new [patent_app_number] => 10/466823 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1601 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115191.pdf [firstpage_image] =>[orig_patent_app_number] => 10466823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7605200 [patent_doc_number] => 07115729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53' [patent_app_type] => utility [patent_app_number] => 10/751088 [patent_app_country] => US [patent_app_date] => 2004-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 8680 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115729.pdf [firstpage_image] =>[orig_patent_app_number] => 10751088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813837 [patent_doc_number] => 07414111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Engineered templates and their use in single primer amplification' [patent_app_type] => utility [patent_app_number] => 10/737252 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 14291 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414111.pdf [firstpage_image] =>[orig_patent_app_number] => 10737252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004592 [patent_doc_number] => 20050169905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/732453 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 20201 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169905.pdf [firstpage_image] =>[orig_patent_app_number] => 10732453 [rel_patent_id] =>[rel_patent_doc_number] =>)